Marshall Wace North America’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,436	Closed	-$25K	–	1334
2019 Q3	$25K	Buy	+3,436	New	+$25K	﹤0.01%	1219
2019 Q1	–	Sell	-5,589	Closed	-$84K	–	1616
2018 Q4	$84K	Buy	+5,589	New	+$84K	﹤0.01%	1117